The Evidence Base for Diabetes Care (eBook)
509 Seiten
John Wiley & Sons (Verlag)
978-0-470-68281-4 (ISBN)
Care has been fully revised and updated to incorporate new
evidence from clinical trials. The aim of the book remains the same
- to provide treatment recommendations based on the latest
research and ensure patients with diabetes receive the best
possible care.
Designed to be user-friendly, the evidence is displayed in clear
tables with accompanying critiques including grading of evidence
where appropriate. As well as summarizing the current evidence
available for diabetes prevention and care, the contributors
highlight areas where evidence is lacking and where studies are
underway.
This book is an invaluable source of evidence-based information
distilled into guidance for clinical practice.
William Herman Professor Herman is an internationally recognized researcher, educator, and clinician in the prevention and treatment of diabetes. He is currently the Director of the Michigan Diabetes Research and Training Center. He has given over 125 invited lectures around the world, and has published eight books, 26 book chapters and almost 150 articles in peer-reviewed journals. He was associate editor for the journals Clinical Diabetes and Diabetes Care. Professor Herman is the recipient of the American Diabetes Association's Kelly West Award for Outstanding Achievement in Epidemiology. Rhys Williams Professor Rhys Williams is Professor of Clinical Epidemiology at the University of Wales, Swansea. He is Vice-President of the International Diabetes Federation (IDF) and Chair of the IDF Task Force on Diabetes Awareness. He is also Chair of Diabetes UK's Wales Advisory Council. His main research interests relate to diabetes and the metabolic syndrome, especially their epidemiology, health services research and economics. Ann Louise Kinmonth Professor Kinmonth is the Foundation Professor of General Practice at the University of Cambridge. She has contributed through research to the management of diabetes and prevention of cardiovascular disease in general practice and is also interested in the impact of genetics on general medical practice. Nick Wareham Professor Wareham is an Honorary Consultant at Addenbrooke's Hospital, Cambridge. He is Director of the MRC Epidemiology Unit and co-Director of the Institute of Metabolic Science. His principal research interests are the aetiology and prevention of obesity and diabetes. He also leads the href="http://www.mrc-epid.cam.ac.uk/Research/Programmes/Programme_1/index.html">Aetiology of Diabetes Programme and is the Clinical Lead for the Eastern England Diabetes Local Research Network.
List of Contributors.
1 The evidence base for diabetes care (William H. Herman, Ann
Louise Kinmonth, Nicholas J. Wareham, Rhys Williams).
Part 1: Evidence-based definition and classification.
2 Classification of diabetes (Maximilian de Courten).
3 Commentary on the classification and diagnosis of diabetes
(Stephen O'Rahilly, Nicholas J. Wareham).
Part 2: Primary and primordial prevention and early
detection.
4 Prevention of type 1 diabetes (Jay S. Skyler).
5 Prevention of type 2 and gestational diabetes (Richard F.
Hamman, Dana Dabelea).
6 The evidence to screen for type 2 diabetes (Michael M.
Engelgau, K.M. Venkat Narayan).
Part 3: Prevention of complications.
7 The effectiveness of interventions aimed at weight loss and
other effects of diet and physical activity in achieving control of
diabetes and preventing its complications (Nita Gandhi Forouhi,
Nicholas J. Wareham).
8 What is the evidence that changing tobacco use reduces the
incidence of diabetic complications? (Deborah L. Wingard,
Elizabeth Barrett-Connor, Nicole M. Wedick).
9 Does intensive glycaemic management reduce morbidity and
mortality in type 1 diabetes? (William H. Herman).
10 Does intensive glycaemic management reduce morbidity and
mortality in type 2 diabetes? (Amanda I. Adler).
11 Glycaemic control and other interventions in the treatment of
gestational diabetes (David R. McCance).
12 Antihypertensive therapy to prevent the cardiovascular
complications of diabetes mellitus (Tonya L. Corbin, Alan B.
Weder).
13 Does treating hyperlipidaemia with medication prevent
complications? (Helen M. Colhoun).
14 Other cardiovascular risk factors (Stephen Thomas,
GianCarlo Viberti).
15 Prevention of the consequences of diabetes - a
commentary (Hertzel C. Gerstein).
Part 4: Treatment of established complications.
16 Treatment of diabetic retinopathy (Ayad Al-Bemani, Roy
Taylor).
17 Prevention and treatment of diabetic nephropathy: the role of
blood pressure lowering (Carl Erik Mogensen).
18 Treatment of established complications: periodontal disease
(George W. Taylor, Wenche S. Borgnakke).
19 Treatment of diabetic neuropathy (Rodica Pop-Busui,
Zachary Simmons, Eva L. Feldman).
20 Treatment of erectile dysfunction (David E. Price,
Geoffrey Hackett).
21 Cardiac complications and management (Anthony S.
Wierzbicki, Simon R. Redwood).
22 The treatment of established complications: cerebrovascular
disease (Devin Brown, Susan L. Hickenbottom).
23 The management of peripheral arterial disease in patients
with type 2 diabetes (Sydney A. Westphal, Pasquale J.
Palumbo).
24 Epidemiology of foot ulcers and amputations in people with
diabetes: evidence for prevention (Gayle E. Reiber, William R.
Ledoux).
Part 5: Self-management, healthcare organization and public
policy.
25 What is the evidence that increasing engagement of
individuals in self-management improves the processes and outcomes
of care? (Debra L. Roter, Ann Louise Kinmonth).
26 Delivering care to the population (Rhys Williams, Ann
John, Ambady Ramachandran, Chamukuttan Snehalatha).
27 Cost-effectiveness of interventions for the prevention and
control of diabetes (Rui Li, Ping Zhang).
28 The role of public policy (Julia Critchley, Nigel
Unwin).
Index.
Erscheint lt. Verlag | 22.12.2009 |
---|---|
Sprache | englisch |
Themenwelt | Sachbuch/Ratgeber ► Gesundheit / Leben / Psychologie |
Medizinische Fachgebiete ► Innere Medizin ► Endokrinologie | |
Studium ► 1. Studienabschnitt (Vorklinik) ► Biochemie / Molekularbiologie | |
Schlagworte | Diabetes • Evidence-based Health Care • Evidenzbasierte Forschung im Gesundheitswesen • Medical Science • Medizin • Zuckerkrankheit |
ISBN-10 | 0-470-68281-7 / 0470682817 |
ISBN-13 | 978-0-470-68281-4 / 9780470682814 |
Haben Sie eine Frage zum Produkt? |
Größe: 4,7 MB
Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine
Geräteliste und zusätzliche Hinweise
Zusätzliches Feature: Online Lesen
Dieses eBook können Sie zusätzlich zum Download auch online im Webbrowser lesen.
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich